Curriculum Vitae
Jeffrey T. Cooper
Education
1987 B.A. Dartmouth College, Hanover, NH
Major: History
Summa Cum Laude
Salutatorian, Class of 1987
1991 M.D. Harvard Medical School, Boston, MA
Residency Training
1991-1992 Intern in Surgery, New England Deaconess Hospital, Boston, MA
1992-1994 Resident in Surgery, New England Deaconess Hospital, Boston, MA
1997-1999 Resident in Surgery, Beth Israel-Deaconess Medical Center, Boston, MA
Fellowship Training
1999-2001 Fellow in Transplant Surgery, University of Wisconsin Hospital and Clinics, Madison, WI
Research Training
1994-1997 Research Fellow, Sandoz Center for Immunobiology, Laboratory of Fritz H.
Bach, New England Deaconess Hospital, Harvard Medical School, Boston, MA
1987 Research Assistant, Department of Neurosurgery, University of Pittsburgh Medical School, Laboratory of Laligham Shakir
Practice Experience
1994-1997 Moonlighter, Department of Cardiothoric Surgery, Mount Auburn Hospital, Cambridge, MA
1994-1997 Moonlighter, Department of Cardiothoracic Surgery, New England Deaconess Hospital, Boston, MA
1999 Emergency Room Physician, Lawrence General Hospital, Lawrence, MA
7/16/01-present Assistant Professor of Surgery, Department of Transplant Surgery, New England Medical Center, Boston, MA
Honors & Awards
Phi Beta Kappa
Rufus Choate Scholar
Memberships
The American Society of Transplant Surgeons
The Massachusetts Medical Society
Board Certification
The American Board of Surgery- 2001
Medical License
Massachusetts Medical License Number 79976
Publications
Ferran, C., Millan, M., Czismadia, V., Cooper, J., Brostjan, C., Bach, F.H., and Winkler, H. Inhibition of NF-kB by Pyrrolidined Dithiocarbamate Blocks Endothelial Cell Activation. Biochem. And Biophysic. Res. Commun. 214(1): 212-223, 1995.
Ferran, C., Cooper, J., Brostjan, C., Stroka, D., Millan, M., Goodman, D., and Bach, F.H. Expression of a Truncated Form of the Human p55 TNF-Receptor in Bovine Aortic Endothelial Cells Renders Them Resistant to Human TNF. Transpl. Proc. 28(2): 618-619, 1996.
Cooper, J., Stroka, D., Brostjan, C., Palmetshofer, A., Bach, F.H. and Ferran, C. A20 Blocks Endothelial Cell Activation Through an NF-kB Dependent Mechanism. J. Biol. Chem. 271(30):18068-73, 1996.
Ferran, C., Badrichani, A., Cooper, J., Stroka, D., and Bach, F.H. Xenotransplantation: Progress Towards Clinical Development. Advances in Nephrology. 1997.
Stroka, D., Cooper, J., Brostjan, C., Millan, M., Goodman, D., Wrighton, C., Bach, F.H., and Ferran, C. Expression of a Negative Dominant Mutant of Human p55 Tumor Necrosis Factor-Receptor Inhibits TNF and Monocyte-Induced Activation in Porcine Aortic Endothelial Cells. Transpl. Proc., 29: 882, 1997.
Ferran, C., Stroka, D., Badrichani, A., Cooper, J., and Bach, F.H. Adenovirus-Mediated Gene Transfer of A20 Renders Endothelial Cells Resistant to Activation: A Means of Evaluating the Role of Endothelial Cell Activation in Xenograft Rejection. Transpl. Proc., 879-880, 1997.
Cooper, J., Stroka, D., Brostjan, C., Palmetshofer, A., Bach, F.H. and Ferran, C. A20 Blocks Endothelial Cell Activation Via NF-kB. Transpl. Proc. 29, 881, 1997.
Ferran, C., Stroka, D., Badrichani, A., Cooper, J., Wrighton, C., Soares, M., Grey, S., Bach, F.H. A20 Inhibits NF-kB Activation in Endothelial Cells Without Sensitizing To Tumor Necrosis Factor-Mediated Apoptosis. Blood. 91 (7): 2249-58, 1998.
Cooper, J. and D’Allesandro, A. Non-Heart –Beating Donors, Double Renal Transplantation and Non-Directed Living Donation in Kidney Transplantation. Current Opinion in Organ Transplantation. 6(1): 64-69, 2001.
Arvelo, M., Cooper J., Longo, C., Daniel, S., Grey, S., Mahiou, J., Czismadia, E., Abu-Jawdeh, G., Ferran, C. A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology. 35(3):535-43, 2002.
Angelis,M., Cooper,J., Freeman,R. Impact of Donor Infections on Outcome of Orthotopic Liver Transplantation. Liver Transplantation. 9(5):451-462,2003.
Doherty E, Huang C, Supran S, Mason T, Angelis M, Cooper J, Rohrer R, Freeman, RB Donor recipient combine cytokine gene polymorphism analysis is associated with recipient infections after solid organ transplantation. ATJ 2003: 5: 3 426
Kinzel J, Dixon M, Melanson A, Palladino M, Horth B, Modak A, Cooper J, Angelis M, Rohrer R, Freeman RB, The phenylalanine breath test (PBT) is a good measure of liver function after human liver surgery. ATJ 2003; 5: 3 246
Mithofer A, Supran S, FitzMaurice S, Bloom J, Pratt D, Epstein M, Angelis M, Cooper J, Rohrer R, Freeman RB Characteristics of patients dying on the waiting list have not changed in the MELD era. Liver Transplantation 2003; 9: 6 C-57
Dixon M, Kinzel J, Melanson M, Horth B, Palladino MB, Modak A, Cooper J, Angelis M, Rohrer R, Freeman RB, The Phenylalanine Breath Test (PBT) is a good measure of liver function after human liver surgery. Liver Transplantation 2003; 9: 6 C-28
Mithoefer A, Supran S, Rohrer RJ, Angelis MA, Cooper J, Pratt DS, Epstein MA, Bankoff M, Fitzmaurice SE, Bloom JS, Freeman RB. Donor residual liver volume to body weight ratios do not correlate with donor complications after living live donation. Amer J Transplantation 2002; 2: S3 305
Mithoefer A, Supran S, Rohrer RJ, Angelis MA, Cooper J, Pratt DS, Epstein MA, Bankoff M, Fitzmaurice SE, Bloom JS, Freeman RB. CT scan-measured liver volumes overestimate calculated standard liver volumes and actual operative liver volumes. Amer J Transplantation 2002; 2: S3 305
Hemming J, Angelis MA, Mithoefer A, Smith J, Cooper J, Pratt DS, Epstein MA, Rohrer RJ, Freeman, RB. Direct costs for one year of liver transplant care are not independently associated with pre-transplant MELD score. Amer J Transplantation. 2002; 2: S3 299.
Cooper J, Chin T, Krieger R, Fernandez L, Foley D, Becker Y, Odorico J, Knechtle S, Kalayoglu M, Sollinger H, D’Alessandro A. Donation After Cardiac Death: The University of Wisconsin Experience With Renal Transplantation. Amer J Transplantation 2004; 4: 1490-4.
Cooper, J. Living Donor Liver Transplantation. Current Surgery. 2005; 62(3).
Presentations
Cooper, J., Stroka, D., Brostjan, C., Palmetshofer, A., Bach, F.H. and Ferran, C. Inhibition of Endothelial Cell Activation by A20, a Novel Zn-finger Protein. Selected for Oral Presentation at the 22nd Annual Scientific Meeting of the American Society of Transplant Surgeons. Dallas, Texas. May 29-31, 1996.
Cooper, J., Stroka, D., Brostjan, C., Palmetshofer, A., Bach, F.H. and Ferran, C. A20 Inhibits Endothelial Cell Activation By a Mechanism Involving NF-kB. Selected for Oral Presentation at the 16th International Congress of the Transplantation Society. Barcelona, Spain. August 25-30, 1996.
Cooper, J., Chin, L.T.,Krieger, N., Fernandez, L., Foley D., Becker, Y.T., Odorico, J.S., Knechtle, S.J., Kalayoglu, M., Sollinger, H.W. , D’Alessandro, A. Results Of Renal Transplants Performed From Non-Heart Beating Donors: The University Of Wisconsin Experience.Selected for Oral Presentation at the American Transplant Congress. Washington, DC. April 26-May 1, 2002